期刊文献+

多肿瘤标志物蛋白芯片检测系统对肝癌的诊断价值 被引量:12

DIAGNOSTIC VALUE OF MULTI-TUMOR MARKER PROTEIN BIOCHIP DETECTIVE SYSTEM FOR LIVER CANCER
下载PDF
导出
摘要 [目的]研究多肿瘤标志物蛋白芯片检测系统对肝癌的诊断价值。[方法]用多肿瘤标志物蛋白芯片检测系统测定分析99例肝癌患者,50例肝炎患者和135例正常人血清中肿瘤标志物(CA199、NSE、CEA、CA242、CA125、CA153、AFP、Fe、f-PSA、PSA、β-HCG、HGH)的水平。[结果]99例肝癌患者有78例血清肿瘤标志物为阳性,阳性率为78.8%;50例肝炎患者有9例血清肿瘤标志物为阳性,阳性率为18.0%;135例正常人血清中没有发现阳性。[结论]多肿瘤标志物蛋白芯片检测系统的应用对肝癌的诊断有较高的临床参考价值。 [Objective] To evaluate the diagnostic Value of multi-tumor marker protein bioehip detective system for liver cancer [ Methods ] Used the multi-tumor markers protein biochip detective system to determine and analyze the concentration values of 12turner markers (CA199, NSE, CEA, CA242, CA125, CA153, AFP, Fe , f-PSA, PSA, β-HCG, HGH)in the serum levels of 99 liver cancer patients, 50 hepatitis patients and 135 normal persons. [Results] At least one kind of tu, mot mark was found higher in 78 sera of the 99 liver cancer patients, positive ratio was 78i8%, in 9 sera of the 50 hepatitis patients, positive ratio was 18.0%, and none of tumor mark was found higher inthe positive in 135 normal persons. [Conclusion] The application of muhi-tumor markers protein biochip deteCtive system in the diagnosing of liver cancer is helpful in clinic.
作者 郑三
出处 《现代预防医学》 CAS 北大核心 2008年第21期4289-4290,4292,共3页 Modern Preventive Medicine
关键词 肝癌 肿瘤标志物 多肿瘤标志物蛋白芯片检测系统 蛋白芯片 Liver cancer Tumor marker Multi-tumor marker protein biochip detective system Protein biochip
  • 相关文献

参考文献13

  • 1yon Eggeling F, Davies H, Lomas L, et al. Tissue-specific microdissection coupled with ProteinChip array technologies: applications in cancer research [J]. Biotechniques, 2000. 29 (5) : 1066-1070.
  • 2Weinberger SR, Dalmasso EA, Fung ET. Current achievements using ProteinChip Array technology [J]. Curt Opin Chem Biol, 2002, 6 (1): 86-91.
  • 3Rubin RB, Merchant M.A rapid protein profiling system that speeds study of cancer and other diseases [J[J]. Am Clin Lab, 2000, 19 (8): 28-29.
  • 4Schneider J, Peltri G, Bitteriich N, et al. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients [J] .Anticancer Res, 2003, 23 (2A): 899-906.
  • 5Johnson PJ: The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular careinoma [J]. Clin Liver Dis 2001 ; 5: 145-159.
  • 6Witzigmann H, Geissler F, Benedix F, et ai. Prospective evalu ation of circulating hepatocytes by alpha-fetoprotein messen ger RNA in patients with hepatocellular carcinoma [J]. surgery, 2002, 131 (1): 34-43.
  • 7Gebo KA, Chander G, Jenekes MW, et al. Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systematie review[J]. Hepatology, 2002, 36 (Ssuppl 1): S84-92. Review.
  • 8Poon TC. Chan AT. Zee B, et al. Application of classification tree and nenral network algorithms to the identificalion of serological liver marker profiles for the diagnosis of hepatoeellular carcinoma [j]. Oncology, 2001, 61 (4): 275-283.
  • 9Parasole R, Izzo F, Pen-one F, et al. Prognostic value of sernm biological markers in patients with hepatocellular carcinoma[J]. Clin Cancer Res, 2001, 7 (11) : 3504-3509.
  • 10Yang EB, Zhao YN, Zhang K, et al. Microsatellite alterations in human hepatocetlular carcinoma infected with hepatitis B virus: associated with the elevation of serum alpha-fetoprotein [J]. Int J Oncol, 2001, 19 (3): 513-518.

共引文献12

同被引文献111

引证文献12

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部